120 related articles for article (PubMed ID: 6265342)
1. Adenylate kinase deficiency and malignant hyperthermia.
Cerri CG; Willner JH; Britt BA; Wood DS
Hum Genet; 1981; 57(3):325-6. PubMed ID: 6265342
[TBL] [Abstract][Full Text] [Related]
2. Hereditary malignant hyperpyrexia associated with muscle adenylate kinase deficiency.
Schmitt J; Schmidt K; Ritter H
Humangenetik; 1974; 24(3):253-7. PubMed ID: 4374418
[No Abstract] [Full Text] [Related]
3. Myoadenylate deaminase deficiency and malignant hyperthermia susceptibility: is there a relationship?
Fishbein WN; Muldoon SM; Deuster PA; Armbrustmacher VW
Biochem Med; 1985 Dec; 34(3):344-54. PubMed ID: 4096721
[TBL] [Abstract][Full Text] [Related]
4. [Creatinine phosphokinase and adenylate kinase activities in skeletal muscle of malignant hyperthermia susceptible patients (author's transl)].
Oku S; Britt BA
Masui; 1981 Aug; 30(8):819-25. PubMed ID: 6275140
[No Abstract] [Full Text] [Related]
5. Comparison of adenylate kinase from normal and malignant hyperpyrexic porcine muscle.
Marjanen LA; Shaw DC; Denborough MA
Biochem Med; 1983 Apr; 29(2):164-70. PubMed ID: 6305346
[TBL] [Abstract][Full Text] [Related]
6. Effect of halothane on adenylate kinase in porcine malignant hyperpyrexia.
Marjanen LA; Denborough MA
Clin Chim Acta; 1982 Jul; 122(2):225-30. PubMed ID: 6286170
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
[TBL] [Abstract][Full Text] [Related]
8. Adenylate kinase and malignant hyperpyrexia.
Marjanen LA; Denborough MA
Br J Anaesth; 1982 Sep; 54(9):949-52. PubMed ID: 6288062
[No Abstract] [Full Text] [Related]
9. Genetic effects on the variability of the halothane and caffeine muscle contracture tests.
Urwyler A; Censier K; Kaufmann MA; Drewe J
Anesthesiology; 1994 Jun; 80(6):1287-95. PubMed ID: 8010475
[TBL] [Abstract][Full Text] [Related]
10. [New aspects in the clinical picture of malignant hyperthermia (author's transl)].
Junger H; Kuhnle P; Schorer R
Z Kinderchir Grenzgeb; 1980 May; 30(1):35-7. PubMed ID: 7456684
[TBL] [Abstract][Full Text] [Related]
11. Masseter muscle rigidity and malignant hyperthermia susceptibility in pediatric patients. An update on management and diagnosis.
O'Flynn RP; Shutack JG; Rosenberg H; Fletcher JE
Anesthesiology; 1994 Jun; 80(6):1228-33. PubMed ID: 8010468
[TBL] [Abstract][Full Text] [Related]
12. Abnormality in calcium release from skeletal sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia.
Nelson TE
J Clin Invest; 1983 Sep; 72(3):862-70. PubMed ID: 6886007
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of susceptibility to malignant hyperthermia in children].
Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
[TBL] [Abstract][Full Text] [Related]
14. The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS.
Allen GC; Larach MG; Kunselman AR
Anesthesiology; 1998 Mar; 88(3):579-88. PubMed ID: 9523799
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylase ratio and susceptibility to malignant hyperthermia.
Traynor CA; Van Dyke RA; Gronert GA
Anesth Analg; 1983 Mar; 62(3):324-6. PubMed ID: 6299136
[TBL] [Abstract][Full Text] [Related]
16. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
Sato N; Brum JM; Mitsumoto H; DeBoer GE
Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
[TBL] [Abstract][Full Text] [Related]
17. Use of the caffeine-halothane contracture test for the diagnosis of malignant hyperthermia in Brazil.
Sudo RT; Cunha LB; Carmo PL; Matos AR; Trachez MM; Cardoso LA; Aguiar MI; Abreu AV; Zapata-Sudo G
Braz J Med Biol Res; 2010 Jun; 43(6):549-56. PubMed ID: 20464345
[TBL] [Abstract][Full Text] [Related]
18. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
[TBL] [Abstract][Full Text] [Related]
19. High skeletal muscle adenylate cyclase in malignant hyperthermia.
Willner JH; Cerri CG; Wood DS
J Clin Invest; 1981 Nov; 68(5):1119-24. PubMed ID: 6271806
[TBL] [Abstract][Full Text] [Related]
20. An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia.
Hopkins PM; Ellis FR; Halsall PJ; Stewart AD
Anesth Analg; 1997 Mar; 84(3):648-56. PubMed ID: 9052318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
